State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.
Department of Pharmacology, School of Medicine, Southeast University, Nanjing 210009, China.
Chin J Nat Med. 2020 Mar;18(3):161-168. doi: 10.1016/S1875-5364(20)30017-0.
The liver is an important metabolic organ and controls lipid, glucose and energy metabolism. Dysruption of hepatic lipid metabolism is often associated with fatty liver diseases, including nonalcoholic fatty liver disease (NAFLD), alcoholic fatty liver diseases (AFLD) and hyperlipidemia. Recent studies have uncovered the contribution of hormones, transcription factors, and inflammatory cytokines to the pathogenesis of dyslipidemia and fatty liver diseases. Moreover, a significant amount of effort has been put to examine the mechanisms underlying the potential therapeutic effects of many natural plant products on fatty liver diseases and metabolic diseases. We review the current understanding of insulin, thyroid hormone and inflammatory cytokines in regulating hepatic lipid metabolism, focusing on several essential transcription regulators, such as Sirtuins (SIRTs), Forkhead box O (FoxO), Sterol-regulatory element-binding proteins (SREBPs). We also discuss a few representative natural products with promising thereapeutic effects on fatty liver disease and dyslipidemia.
肝脏是一个重要的代谢器官,控制着脂质、葡萄糖和能量代谢。肝脂质代谢紊乱常与脂肪肝疾病有关,包括非酒精性脂肪性肝病(NAFLD)、酒精性脂肪性肝病(AFLD)和高脂血症。最近的研究揭示了激素、转录因子和炎性细胞因子在血脂异常和脂肪肝疾病发病机制中的作用。此外,人们还投入了大量精力来研究许多天然植物产物对脂肪肝疾病和代谢疾病的潜在治疗作用的机制。我们综述了目前对胰岛素、甲状腺激素和炎性细胞因子调节肝脂质代谢的认识,重点介绍了几种重要的转录调节因子,如沉默调节蛋白(SIRTs)、叉头框蛋白 O(FoxO)、固醇调节元件结合蛋白(SREBPs)。我们还讨论了几种有希望治疗脂肪肝疾病和血脂异常的代表性天然产物。